Literature DB >> 25503581

Effect of probiotic supplementation on bacterial translocation in common bile duct obstruction.

Fatma Sarac1, Tansu Salman, Feryal Gun, Alaaddin Celik, Nezahat Gurler, Semra Dogru Abbasoglu, Vakur Olgac, Ayse Saygili.   

Abstract

OBJECTIVE: To investigate the effects of probiotics on bacterial translocation in the obstructive common bile duct with comparison to an enteral product containing arginine and glutamine. MATERIAL AND
METHOD: In our study, 40 Sprague-Dawley rats each weighing 250-300 g were used. Animals in Group 1 (sham) were laparatomized and fed standard chow supplemented with physiologic saline at daily doses of 2 ml through orogastric tube for 7 days. Common bile ducts of the animals in the other groups were ligated with 3/0 silk sutures. Group 2 (control group) was fed standard chow supplemented with daily doses of 2 ml physiologic saline. Group 3 (probiotic group) was fed standard chow supplemented with a probiotic solution (Acidophilus plus) containing strains of Lactobacillus acidophilus, Bifidobacterium bifidum and Lactobacillus bulgaricus at a daily doses of 2 × 10(9) colony forming units (CFU). Group 4 (formula group) was fed only an enteral solution (Stresson Multi Fiber) containing glutamine, arginine and a medium-chain fatty acid at daily doses of 2 g/kg. At the end of the 7th day, all animals were relaparatomized, and to determine bacterial translocation, aerobic, and anaerobic cultures were obtained from the specimens of mesenteric lymph nodes, intestinal mucosa, and blood samples. Smear cultures prepared from caecum were examined to determine the number of CFU. Finally, for histological examination specimens were excised from terminal ileum, and oxidative damage was assessed in liver tissues. Afterwards all animals were killed.
RESULTS: Moderately lesser degrees of bacterial translocation, and mucosal damage were seen in Groups 3, and 4 relative to Group 2 (p < 0.05). In Group 4, any difference was not seen in the number of cecal bacteria relative to baseline values, while in Group 3, significant decrease in cecal colonization was seen. Among all groups, a significant difference between levels of malondialdehyde, and glutathione was not observed.
CONCLUSION: At the end of our study, we have concluded that both probiotics, and enteral diets which contain immunomodulators such as glutamine, and arginine alleviate bacterial translocation, and impairment of intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25503581     DOI: 10.1007/s00383-014-3643-2

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  42 in total

Review 1.  Prophylactic and therapeutic uses of probiotics: a review.

Authors:  L Kopp-Hoolihan
Journal:  J Am Diet Assoc       Date:  2001-02

2.  Bacterial translocation and glutamine.

Authors:  Paolo R O Salvalaggio; Antonio C L Campos
Journal:  Nutrition       Date:  2002-05       Impact factor: 4.008

Review 3.  Multifactorial gut barrier failure in cirrhosis and bacterial translocation: working out the role of probiotics and antioxidants.

Authors:  Agustín Albillos; Antonio de la Hera
Journal:  J Hepatol       Date:  2002-10       Impact factor: 25.083

4.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

5.  The effect of an H2-receptor antagonist on small-bowel colonization and bacterial translocation in newborn rats.

Authors:  U N Başaran; S Celayir; N Eray; R Oztürk; O F Senyüz
Journal:  Pediatr Surg Int       Date:  1998-03       Impact factor: 1.827

6.  Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.

Authors:  Tilman Martin Bauer; Javier Fernández; Miquel Navasa; Jordi Vila; Juan Rodés
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

7.  Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model.

Authors:  D Adawi; S Ahrné; G Molin
Journal:  Int J Food Microbiol       Date:  2001-11-08       Impact factor: 5.277

8.  Influence of glutamine-supplemented parenteral nutrition on intestinal amino acid metabolism in rats after small bowel resection.

Authors:  K Chen; R Nezu; K Sando; S M Haque; Y Iiboshi; A Masunari; H Yoshida; S Kamata; Y Takagi; A Okada
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

9.  Increased intestinal permeability associated with infection in burn patients.

Authors:  T R Ziegler; R J Smith; S T O'Dwyer; R H Demling; D W Wilmore
Journal:  Arch Surg       Date:  1988-11

Review 10.  Glutathione metabolism and its role in hepatotoxicity.

Authors:  L D DeLeve; N Kaplowitz
Journal:  Pharmacol Ther       Date:  1991-12       Impact factor: 12.310

View more
  4 in total

1.  Effects of Probiotic Use on Bacterial Translocation in Created Rat Models with Biliary Obstructions.

Authors:  Mehmet Emin Celikkaya; Bulent Akcora; Sibel Hakverdi; Burcin Ozer; Kemal Turker Ulutas; Nizami Duran
Journal:  Eurasian J Med       Date:  2019-06

2.  Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of DNAemia.

Authors:  T Gosiewski; A H Ludwig-Galezowska; K Huminska; A Sroka-Oleksiak; P Radkowski; D Salamon; J Wojciechowicz; M Kus-Slowinska; M Bulanda; P P Wolkow
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-22       Impact factor: 3.267

3.  Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study.

Authors:  Shin-Yi Tsai; Hsuan-Ju Chen; Chon-Fu Lio; Chien-Feng Kuo; An-Chun Kao; Wei-Shieng Wang; Wei-Cheng Yao; Chi Chen; Tse-Yen Yang
Journal:  J Transl Med       Date:  2019-02-22       Impact factor: 5.531

4.  Better detoxifying effect of ripe forsythiae fructus over green forsythiae fructus and the potential mechanisms involving bile acids metabolism and gut microbiota.

Authors:  Tao Wang; Xu-Jiong Li; Ling-Hao Qin; Xue Liang; Huan-Huan Xue; Jing Guo; Shi-Fei Li; Li-Wei Zhang
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.